Ken Griffin acquired 5.93 Thousand Celldex Therapeutics shares worth $187 Thousand. That's 0.00% of their equity portfolio (4220th largest holding). The first Celldex Therapeutics trade was made in Q4 2019. Since then Ken Griffin bought shares eight more times and sold shares on six occasions. The investor's estimated purchase price is $200 Thousand, resulting in a loss of 6.4%.